| Ovarian Carcinosarcoma studied in …STUDIED_INderived30 of 30show fewer |
|---|
| → studied in | NCT05920798Phase 1/Phase 2 · active not recruiting Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped CURATED_BROADER · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651206Phase 2/Phase 3 · recruiting Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741968NA · recruiting A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06580314Phase 3 · recruiting Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04092270Phase 1 · active not recruiting A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer · condition mapped CURATED_BROADER · 30 trials mapped (12 active) | — | — | Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03449108Phase 2 · active not recruiting LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04919629Phase 2 · recruiting APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05500391Phase 2 · recruiting Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06483048Phase 1 · recruiting MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer · condition mapped CURATED_BROADER · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02364713Phase 2 · terminated MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902988Phase 1/Phase 2 · recruiting A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639074Phase 2 · recruiting Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial · condition mapped CURATED_BROADER · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06393751Phase 1/Phase 2 · withdrawn Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03610490Phase 2 · terminated Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03648489Phase 2 · completed Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03206177Phase 1 · completed Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03641287NA · terminated The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05537844unknown Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03924245Phase 1 · terminated Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00989651Phase 1 · completed Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00954174Phase 3 · unknown Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02993705Phase 2 · completed Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS) · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085358Phase 1 · completed Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01010126Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01080521completed Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00511992Phase 2 · completed Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390234Phase 2 · completed Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352300Phase 1 · completed Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer · condition mapped ONTOLOGY_EXACT · 30 trials mapped (12 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |